Abstract
Blockade of the human ether-a-go-go related gene 1 (hERG1) channel has been associated with an increased duration of ventricular repolarization, causing prolongation of the time interval between Q and T waves (long QT syndrome, or LQTS). LQTS may result in serious cardiovascular disorders such as tachyarrhythmia and sudden cardiac death. Diverse types of organic compounds bind to the wide intracellular cavity in the pore domain of hERG channels, leading to a full or partial blockade of ion current through the pore. The drug– induced blockade of the hERG-related component of the potassium current is thought to be a major reason for drug– induced arrhythmias in humans. Identification of specific interactions governing the high-affinity blockade of cardiac potassium (K–) channels is crucial both for the prevention of unintended ion channel block and for the design of ion channel modulators. A plethora of ligand- and receptor-based models of K-channels have been created to address these challenges. In this paper, we review the current state of knowledge regarding the structure-function relationship of hERG and discuss progress in the use of molecular modeling for developing both blockers and activators of hERG.
Keywords: hERG, biological channels, long QT syndrome, channel activation and blockade, blockers and activators of hERG, hERG screening, potent modeling strategies of ion channels, hERG1, Drugs, ventricular repolarization, ligand- and receptor-based models, structure-function relationship, potent modeling, strategies of ion channels, transmembrane, anti-arrhythmic activity, proarrhythmic-drug-induced LQTS, non-cardiac medications, antibiotics, antihistamines, antibacterials, terfenadine, cisapride, astemizole, grepafloxin
Current Medicinal Chemistry
Title: Insights into the Molecular Mechanism of hERG1 Channel Activation and Blockade by Drugs
Volume: 17 Issue: 30
Author(s): S. Durdagi, J. Subbotina, J. Lees-Miller, J. Guo, H. J. Duff and S. Y. Noskov
Affiliation:
Keywords: hERG, biological channels, long QT syndrome, channel activation and blockade, blockers and activators of hERG, hERG screening, potent modeling strategies of ion channels, hERG1, Drugs, ventricular repolarization, ligand- and receptor-based models, structure-function relationship, potent modeling, strategies of ion channels, transmembrane, anti-arrhythmic activity, proarrhythmic-drug-induced LQTS, non-cardiac medications, antibiotics, antihistamines, antibacterials, terfenadine, cisapride, astemizole, grepafloxin
Abstract: Blockade of the human ether-a-go-go related gene 1 (hERG1) channel has been associated with an increased duration of ventricular repolarization, causing prolongation of the time interval between Q and T waves (long QT syndrome, or LQTS). LQTS may result in serious cardiovascular disorders such as tachyarrhythmia and sudden cardiac death. Diverse types of organic compounds bind to the wide intracellular cavity in the pore domain of hERG channels, leading to a full or partial blockade of ion current through the pore. The drug– induced blockade of the hERG-related component of the potassium current is thought to be a major reason for drug– induced arrhythmias in humans. Identification of specific interactions governing the high-affinity blockade of cardiac potassium (K–) channels is crucial both for the prevention of unintended ion channel block and for the design of ion channel modulators. A plethora of ligand- and receptor-based models of K-channels have been created to address these challenges. In this paper, we review the current state of knowledge regarding the structure-function relationship of hERG and discuss progress in the use of molecular modeling for developing both blockers and activators of hERG.
Export Options
About this article
Cite this article as:
Durdagi S., Subbotina J., Lees-Miller J., Guo J., J. Duff H. and Y. Noskov S., Insights into the Molecular Mechanism of hERG1 Channel Activation and Blockade by Drugs, Current Medicinal Chemistry 2010; 17 (30) . https://dx.doi.org/10.2174/092986710792927886
DOI https://dx.doi.org/10.2174/092986710792927886 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
Call for Papers in Thematic Issues
Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.
The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more
Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications
The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more
Chalcogen-modified nucleic acid analogues
Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more
Current advances in inherited cardiomyopathy
Describe in detail all novel advances in multimodality imaging related to inherited cardiomyopathy diagnosis and prognosis. Shed light to deeper phenotypic characterization. Acknowledge recent advances in genetics, genomics and precision medicineread more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Functional Genomics in Zebrafish as a Tool to Identify Novel Antiarrhythmic Targets
Current Medicinal Chemistry Role of Statins in Peri-Operative Medicine
Current Drug Targets Surgical or Interventional Revascularization in Diabetic Patients with Coronary Artery Disease?
Current Diabetes Reviews Pharmacogenetics of Antihypertensive Therapies: Can this be Applied in the Clinic?
Current Pharmacogenomics and Personalized Medicine Potential of Sulphur-containing Amino Acids in the Prevention of Catecholamine-induced Arrhythmias
Current Medicinal Chemistry Plasmid DNA Gene Therapy by Electroporation: Principles and Recent Advances
Current Gene Therapy Hypotensive Peptides from Snake Venoms: Structure, Function and Mechanism
Current Topics in Medicinal Chemistry Misoprostol-induced Acute Coronary Syndrome in a Premenopausal Woman: A Case Report with Literature Review
Current Drug Safety Manipulation of Intracellular pH in Cancer Cells by NHE1 Inhibitors
Protein & Peptide Letters Gender and Cardiovascular Mortality in Northern and Southern European Populations
Current Pharmaceutical Design New Chemotherapy and Immunotherapy for Tuberculosis
Current Respiratory Medicine Reviews Hypertension in Obstructive Sleep Apnoea
Vascular Disease Prevention (Discontinued) Psychosocial Factors and Diabetes Mellitus: Evidence-Based Treatment Guidelines
Current Diabetes Reviews Anesthetic Cardioprotection in Clinical Practice From Proof-of-Concept to Clinical Applications
Current Pharmaceutical Design Aesthetic Cardiology: Adipose-Derived Stem Cells for Myocardial Repair
Current Stem Cell Research & Therapy Potential Risks and Mitigation Strategies Before the Conduct of a Clinical Trial: An Industry Perspective
Reviews on Recent Clinical Trials Nifedipine Blocks Ondansetron Electrophysiological Effects in Rabbit Purkinje Fibers and Decreases Early Afterdepolarization Incidence
Current Clinical Pharmacology Lysophospholipids: Synthesis and Biological Aspects
Current Organic Chemistry Editorial (Thematic Issue: Anderson Fabry Disease: A Multiorgan Metabolic Disease Susceptible of Treatment)
Current Pharmaceutical Design Updates on HCN Channels in the Heart: Function, Dysfunction and Pharmacology
Current Drug Targets